OOIR: Observatory of International Research

Papers

(The TQCC of Digestive and Liver Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma	77
Autoimmune atrophic gastritis and coeliac disease: A case-control study	60
Multiple small intestinal ulcers with SLCO2A1 mutation in a Chinese patient	58
Inflammatory bowel disease epidemiology data from a prospective registry in Córdoba, Argentina: Raising the bar for future studies in Latin America	53
Do glucagon-like peptide-1 based therapies alter the risk of late-onset inflammatory bowel disease?	48
AF.82 THE ROLE OF THE PNPLA3, TM6SF2 AND MBOAT7 GENETIC VARIANTS IN THE RESPONSE TO NUTRACEUTICAL THERAPY FOR NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS	45
T.10.4 INTESTINAL ULTRASONOGRAPHY PROFILING OF PATIENTS WITH CROHN'S DISEASE PREDICTS LONG TERM CLINICAL REMISSION	45
Editorial Board	45
AF.83 USEFULNESS OF ELASTOMETRY IN EVALUATING THE EXTENTS OF LIVER FIBROSIS AND RISK OF NON HEPATIC COMPLICATION IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN DIABETIC PATIENTS TYPE 2 (DM2)	44
AF.112 ENDOROTOR-BASED ENDOSCOPIC NECROSECTOMY IN COMPLICATED WALLED-OFF PANCREATIC NECROSIS: A CASE REPORT	42
T.11.7 THE PROGNOSTIC ROLE OF RADIOMICS IN GASTRO-ENTEROPANCREATIC NEUROENDOCRINE TUMORS	42
V.01.7 COMPLETE INTRA-PERITONEAL MALDEPLOYMENT OF A LAMS DURING EUS-GEA FOR MGOO: RESCUE RETRIEVAL WITH PERITONEOSCOPY THROUGH NOTES	37
Application of Machine Learning Model-3P to Predict Portal Hypertension in Patient with Hepatocellular Carcinoma	37
Does HLA-G play a role in PBC?	35
Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome - acute kidney injury	34
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy	34
Impact of laparoscopic liver resection for access to the waiting list of a single regional liver transplant center in southern Italy: entry and dropout flows’ analysis	31
Impact of ISO score on oncological outcomes and survival in liver transplant candidates with hepatocellular carcinoma	31
Characteristics and management of hepatocellular carcinoma (HCC) in Sicily: first results of the HCC Sicily Multidisciplinary Network	31
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC	30
The impact of bacterial infections on cirrhosis complications in a cohort of cirrhotic patients in a northern Italian hospital	29
Recurrent IgG4 cholangitis after liver transplantation: Back to the future	28
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis	28
Comment on “Effect of vessels that encapsulate tumor clusters (VETC) and different stages of hepatocellular carcinoma after hepatectomy”	28
Venous hepatic aneurysms	28

An unusual lesion of the gallbladder mimicking gallbladder carcinoma	27
Brain metastasis from hepatic cholangiolocellular carcinoma in a young female without chronic liver disease	27
Assessment of sarcopenia with ultrasound-based measurements in patients with liver cirrhosis and correlation with clinical outcomes	26
Cardiometabolic risk factors and clinical course of liver cirrhosis	26
Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP	25
Full Title Page /Editorial Board	25
Identification of causes and patterns of albumin structural damages in commercial formulations	25
Safety of same day discharge after Zenker's diverticulum peroral endoscopic myotomy	25
V.04.5: OVER THE SCOPE CLIPS: A RESCUE THERAPY FOR DUODENAL PERFORATION DUE TO BILIARY STENT MIGRATION	24
Fully automated approach of machine learning combined with deep learning: How to predict the onset of major cardiovascular events in NAFLD patients	24
OC.08.4: ARTIFICIAL INTELLIGENCE TOOLS PREDICT EOSINOPHILIC ESOPHAGITIS IN ADULTS REPORTING DYSPHAGIA: DEVELOPMENT, EXTERNALVALIDATION, AND SOFTWARE CREATION FOR POINT-OF-CARE USE	24
BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOFACITINIB-TREATED HUMAN BIOPSIES FROM ACTIVE ULCERATIVE COLITIS PATIENTS TO PREDICT CLINICAL RESPONSE (THE AVATAR STUDY)	24
T.04.5: COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOWED NO DIFFERENCES IN IMMUNOGENICITY OR TREATMENT PERSISTENCE AT ONE YEAR	23
Relationship between recipient/donor features and liver stiffness measurement in the first year after liver transplantation	23
T.04.4: CLINICAL OUTCOME AFTER CROHN'S DISEASE-RELATED SURGERY DIFFERENT FROM ILEO-COLONIC RESECTION	23
NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension	23
Mapping the hepatic mtDNA genomic landscape in patients with MASLD: The Era of GPT-4 Artificial Intelligence	23
OC.01.3: EVENING CHRONOTYPE CORRELATES WITH SEVERITY OF FUNCTIONAL DYSPEPSIA AND AFFECT SLEEP QUALITY	23
T.12.2: THE LEVELS OF AFP, PIVKA-II AND GPC-3 SERUM BIOMARKERS AT DIAGNOSIS CORRELATE WITH HCC CLINICAL-PATHOLOGICAL FEATURES AND WITH OVERALL SURVIVAL	22
OC.04.1 SURGERY IN HIGH-RISK PAEDIATRIC CROHN'S DISEASE TREATED WITH UP-FRONT ANTI-TNF AGENTS AND LONG-STANDING BIOLOGIC THERAPY	21
Collateral intrahepatic circulation in presence of hepatic veins obstruction: The “half-moon”	21
OC.03.4 PREVALENCE OF AUTOIMMUNE ATROPHIC GASTRITIS IN A GASTROENTEROLOGICAL SETTING BY USING AN EXTENSIVE SCREENING STRATEGY VS A CASE FINDING STRATEGY	21
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: A single-center experience	21
Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients	21
AF.43 SOCIAL FUNCTIONING, WORK-PRODUCTIVITY AND PSYCHOLOGICAL ASSESSMENT IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN OBSERVATIONAL STUDY	20
OC.02.3 DEVELOPING AND VALIDATING A DEATH SCORE RISK IN NONVARICEAL UPPER GI BLEEDING PATIENTS (RE.CO.DE SCORE): A PROSPECTIVE MULTICENTER COHORT STUDY	20
OC.03.9 SPARING SPLENIC ARTERY: RADIOLOGICAL-ASSISTED DIRECT ENDOSCOPIC NECROSECTOMY USING ENDOROTOR	20
OC.06.4 DEMOGRAPHIC DIFFERENCES IN LEFT-TO-RIGHT SHIFT OF COLON CANCER OVER 25 YEARS: RESULTS FROM ROBUST ANALYSIS OF CANCER REGISTRY DATA	20
OC.12.5 MYOSTEATOSIS IS NOT ASSOCIATED WITH COMPLICATIONS OR SURVIVAL IN HCC PATIENTS UNDERGOING TRANS ARTERIAL EMBOLIZATION	20
OC.03.8 SAFE AND EFFICACY OF SINGLE CENTRAL ENDOSCOPIC ULTRASOUND GUIDED NEUROLYSIS OF CELIAC PLEXUS FOR PAIN RELIEF IN UNRESECTABLE PANCREATIC CANCER PATIENTS	20
T.01.6 THE EFFICACY OF SIX-FOOD ELIMINATION DIET IS LOWER DURING POLLEN SEASON IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS SENSITIZED TO POLLENS	20
T.05.10 CLINICAL HETEROGENEITY OF ADULT COELIAC DISEASE ACCORDING TO THE AGE AT ONSET: AN ITALIAN MULTICENTRIC STUDY	20
OC.03.1 URGENT ERCP WITH SPHINCTEROTOMY VERSUS CONSERVATIVE TREATMENT IN THE MANAGEMENT OF ACUTE BILIARY PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS	20
PC.01.1 LAPAROSCOPIC VERSUS EUS-GUIDED GASTROENTEROSTOMY FOR GASTRIC OUTLET OBSTRUCTION: AN INTERNATIONAL MULTICENTER PROPENSITY SCORE-MATCHED COMPARISON	20
Factors associated with prior acute pancreatitis episodes among patients with chronic pancreatitis	19
T.01.2 SEVERE OBESITY IMPAIRS POST-REFLUX SWALLOW-INDUCED PERISTALTIC WAVE INDEX REGARDLESS OF ACID EXPOSURE	19
AF.61 PROSPECTIVE, OBSERVATIONAL STUDY OF PROPHYLACTIC VEDOLIZUMAB TREATMENT IN PREVENTING POSTOPERATIVE RECURRENCE (POR) IN HIGH-RISK CROHN’S PATIENTS	19
T.08.8 IMPACT OF METFORMIN ON THE INCIDENCE OF HUMAN CHOLANGIOCARCINOMA IN DIABETIC PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS	19
PC.01.7 EUS-GUIDED FINE-NEEDLE BIOPSY OF SOLID LESIONS WITH OR WITHOUT MACROSCOPIC ON-SITE EVALUATION (MOSE): A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL	19
Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth	19
T.03.5 CLINICAL AND LABORATORY FEATURES OF ANEMIA IN SUBJECTS SUFFERING FROM COELIAC DISEASE	19
OC.11.3 LAPAROSCOPIC HELLER DOR IS AN EFFECTIVE TREATMENT FOR ESOPHAGEAL-GASTRIC JUNCTION OUTFLOW OBSTRUCTION	19
OC.09.5 ADVANCING IN ERCP: THE SLIM DUODENOSCOPE AS A CORNERSTONE FOR CHALLENGING ANATOMIES – INSIGHTS FROM AN ITALIAN CASE SERIES	18
OC.17.5 ENDOSCOPIC VACUUM THERAPY (EVT) FOR THE MANAGEMENT OF UPPER GASTROINTESTINAL TRACT LEAKS AND DEFECTS: A RETROSPECTIVE STUDY FROM ATERTIARY REFERRAL CENTER IN NEARLY 100 PATIENTS	18
T.03.5 EVALUATION OF RECTALWALL THICKNESS MEASUREMENT SENSITIVITY VIA TRANSABDOMINAL ULTRASOUND TO ASSESS MUCOSAL ACTIVITY IN ULCERATIVE COLITIS: COULD THIS BE A USEFUL NON-INVASIVE TOOL? A PRELIMINAR	18
OC.22.3 THREE-YEAR OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY BY OBESITY CLASS	18
OC.04.7 EFFECT OF MTOR INHIBITION ON EXOSOMES ISOLATED FROMPC CELLS WITH DIFFERENT KRAS MUTATIONS	18
Beyond inflammation: Expanding the horizon on vascular risk assessment in inflammatory	18
OC.09.9 BALANCING RISKS AND BENEFITS: EVALUATING THE SAFETYAND EFFICACY OF CHOLANGIOPANCREATOSCOPY IN ELDERLY AND FRAIL POPULATIONS	18
T.08.4 PRELIMINARY DATA FROM AN ONGOING MULTICENTER STUDY: EVALUATION OF THE DIAGNOSTIC ACCURACY OF CHATGPT-4 IN THE RECOGNITION AND CLASSIFICATION OF ESOPHAGEAL VARICES	18

T.10.4 APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD) SAFETY PROFILE: PILOT DATA	17
Antitissue transglutaminase antibodies’ normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience	17
Mesenteric panniculitis is associated with cardiovascular risk-factors: A case-control study	17
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU	17
Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis	17
The impact of reader fatigue on the accuracy of capsule endoscopy interpretation	17
Outcomes and predictors of delayed endoscopic biliary drainage for severe acute cholangitis due to choledocholithiasis in an intensive care unit	17
The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease	17
Renal cell carcinoma metastasis as an atypical cause of gastrointestinal bleeding	17
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study	17
Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studies	17
Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly	16
Author's Reply: “NRF2 in cancer: An insufficiently explored and controversial research area”	16
How macronutrients and pancreatic enzyme supplements dose variability affect fat, protein and starch absorption in children with cystic fibrosis	16
Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study	16
Ileocaecal Crohn's disease. To resect or not to resect, is that the question?	16
Non-anesthesiologist sedation (NAS): The Italian retrotopia needs to be overcome	16
A two-sample Mendelian randomization study to identity microbiome signatures in patients with Non-alcoholic fatty liver disease	16
Comment on ``Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignancies''	16
Cannulation rates and technical performance evaluation of commericially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis	16
Digital single-operator cholangioscopy in diagnostic and therapeutic bilio-pancreatic diseases: A prospective, multicenter study	16
ABCA8: A potential therapeutic target in the treatment of colorectal cancer?	16
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial	16
Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus	16
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study	16
Establishing a nomogram for predicting necrotizing enterocolitis in premature infants: A retrospective multicenter cohort study	16
A new tool for rapid evaluation of endoscopic ultrasound through the needle biopsy in pancreatic cystic neoplasm	15
T.01.10 ITALIAN SOCIETY FOR DIGESTIVE ENDOSCOPY (SIED), ITALIAN ASSOCIATION OF HEALTHCARE TECHNICAL OPERATORS (ANOTE) AND ACCREDITATION ASSESSMENT: EVALUATION OF MANAGEMENT AND ORGANIZATIONAL EFFICACY	15
Safety and immunogenicity of booster dose in patients with chronic liver disease	15
OC.01.1 EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY	15
OC.11.3 THERAPEUTIC EFFECTS OF MELATONIN IN COMBINATION WITH LACTOBACILLUS RHAMNOSUS GG IN PEDIATRIC FUNCTIONAL ABDOMINAL PAIN DISORDERS: A PILOT CLINICAL STUDY	15
Advancing endoscopic papillectomy: Outcomes and insights from a single-center learning experience	15
OC.06.9 ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE	15
OC.03.1 THE SAME FACTORS IMPACT DIFFERENTLY ON TIME TO DEATH IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE COHORT STUDY	15
PC.01.3 LONG-TERM OUTCOME OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM THE PEDIATRIC IBD PORTO GROUP OF ESPGHAN	15
SIRT5 rs12216101 T>G variant is associated with oxidative stress and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease	15
OC.05.3 SEROLOGIC DIAGNOSIS OF CELIAC DISEASE IN ADULTS: AN UNFULFILLED QUESTION	15
OC.12.1 QUANTITATIVE HBV/HDV MARKERS HELP TO DISTINGUISH DIFFERENT CLINIC/VIROLOGIC PHASES OF CHRONIC HEPATITIS DELTA	15
Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement	15
OC.05.5 ENDOSCOPIC TISSUE ACQUISITION DURING ERCP IN BILIARY STENOSIS: RETROSPECTIVE ANALYSIS OF CASES FROM A TERTIARY REFERRAL HOSPITAL	15
Hyperkalemia in patients with cirrhosis and acute-on-chronic liver failure	14
Clinical utility of a targeted panel sequencing for the diagnosis of chronic hereditary liver diseases in adult patients	14
OC.03.6 DUODENAL GASTRIC METAPLASIA AND DUODENAL NEUROENDOCRINE NEOPLASMS: TRUE CAUSALITY OR SIMPLE COINCIDENCE?	14
OC.17.3: HOT VS COLD EMR: AWELL-KNOWN DUALISM IN A NORTHEASTERN ITALIAN EXPERIENCE	14
BOC.01.7: EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF SEVERE AND SEVERE-COMPLICATED CLOSTRIDIOIDES DIFFICILE INFECTION: REPORT FROM A LARGE-VOLUME FMT CENTER	14
BOC.02.8: DEFINING DIAGNOSTIC ULTRASONOGRAPHIC PARAMETERS IN ULCERATIVE COLITIS: A LONGITUDINAL PROSPECTIVE MULTICENTER STUDY	14
T.04.6: ERECTILE AND PROSTATIC DYSFUNCTION IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE	14
Comparison of metabolic alterations, hepatic and cardiovascular damage between primary NAFLD and HIV-associated NAFLD: Role of low visceral adiposity	14
Comparison of severity of liver damage and metabolic alterations in patients with NAFLD attending the hepatology clinic over the last three decades	14
OC.07.6: THE BURDEN OF PSYCHIATRIC MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW WITH META-ANALYSIS	14
OC.01.7: AN EMILIN1-ALTERED MICROENVIRONMENT PROMOTES TUMORCELL PROLIFERATIONAND LYMPHATIC DYSFUNCTION IN GASTRIC CANCER	14
T.04.7: ADHERENCE TO MEDITERRANEAN DIET AND DIET QUALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER, OBSERVATIONAL CASE-CONTROL STUDY	14
PC.01.6 EVOLUTION OF THE RESIDENT MICROBIOTA IN GASTRIC CARCINOGENESIS	14
V.03.5: CHOLANGIOSCOPIC DIAGNOSIS OF AN INTRADUCTAL PAPILLARY BILIARY NEOPLASM: A RARE CAUSE OF BILIARY STRICTURE	14
OC.02.5: METABOLIC DISORDERS IN COELIAC DISEASE AFTER GLUTENFREE DIET	14
T.03.4: ENDOSCOPIC EVALUATION OF NEWLY REPORTED INTESTINAL WALL THICKENING: PRELIMINARY RESULTS	14
OC.20.5 REAL-TIME ELASTOGRAPHY AS A PREDICTOR OF INTESTINAL WALL FIBROSIS IN CROHN’S DISEASE	13
OC.17.3 PERORAL ENDOSCOPIC MYOTOMY FOR SPASTIC ESOPHAGEAL MOTILITY DISORDERS: A SINGLE-CENTER RETROSPECTIVE ANALYSIS	13
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices	13
OC.14.3 THE ANTHELMINTIC DRUG RAFOXANIDE PROMOTES OXIDATIVE STRESS AND VDAC1 OPENING LEADING TO MITOCHONDRIAL DYSFUNCTION IN COLORECTAL CANCER CELLS	13
VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway	13
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis	13
Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, an	13
OC.05.5 HUMAN EXTRACHROMOSOMAL CIRCULAR DNA (ECCDNA) IS A NOVEL BIOMARKER IN INFLAMMATORY BOWEL DISEASE	13
OC.10.1 MASLD AND FIB4 ARE INDEPENDENT PREDICTORS OF MAJOR ADVERSE LIVER OUTCOMES AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: FINDINGS FROM A SINGLE-CENTER COHORT USING AI-DRIVEN MACHINE LEARNING	13
OC.22.4 “REALWORLD” PERCUTANEOUS ENDOSCOPIC GASTROSTOMY MANAGEMENT IN ENDOSCOPY CENTRES	13
Integrating AI in medicine: Lessons from Chat-GPT's limitations in medical imaging	13
Author's Reply: “Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?”	13
V.02.7 THROUGH THE LAMS INTERVENTION AFTER ENDOSCOPIC ULTRASOUND-GUIDED RESIDUAL GALLBLADDER DRAINAGE AS RESCUE TREATMENT IN NON SURGICAL CANDIDATE WITH RECURRENT BILIARY ABDOMINAL PAIN	13
Prevalence of undiagnosed celiac disease in the adult general population of Italy in 1990: Baseline reference for testing current increasing incidence?	13
OC.05.1 ROLE OF RADIOMICS IN PREDICTING THE DEGREE OF INTESTINAL FIBROSIS IN PATIENTS WITH CROHN’S DISEASE	13
OC.22.1 PREVALENCE OF SARCOPENIA IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OBSERVATIONAL STUDY IN A TERTIARY CARE CENTRE	13
BOC.01.2 TRANSORAL SEPTOTOMY VERSUS Z-POEM IN THE TREATMENT OF ZENKER DIVERTICULUM: A MULTICENTER CASE-MATCHED COMPARATIVE STUDY	13
T.10.7 WELCOME TO THE APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD): A PROSPECTIVE OBSERVATIONAL REGIONAL DATABASE ON THE SAFETY AND EFFECTIVENESS OF ALL LICENSED THERAPIES. WHAT IS THE ENRO	13
Tofacitinib in ulcerative colitis – In the era of precision medicine’	13
Cure after surgery for hepato-pancreato-biliary cancers: A systematic review	13
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review	13
Chronic pancreatitis and prior acute pancreatitis episodes	13
Intractable diarrhea in infancy and molecular analysis: We are beyond the tip of the iceberg	12
T.03.1 IMPACT OF GENDER ON CLINICAL MANIFESTATIONS OF COELIAC DISEASE AT THE TIME OF DIAGNOSIS AND FOLLOW-UP	12

Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade	12
Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes	12
AF.162 ESOPHAGEAL ACHALASIA: SUCCESSFUL MULTIDISCIPLINARY APPROACH IN DIAGNOSIS AND THERAPEUTIC MINIMALLY INVASIVE ROBOTIC SURGERY	12
Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension	12
AF.103 CHANGES OF THE DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE NOT RELATED WITH BILE AND PANCREATIC DUCT OBSTRUCTION	12
AF.124 EFFECTIVENESS AND SAFETY OF 1L PEG-ASC PREPARATION FOR COLONOSCOPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES	12
T.12.6 ALARMING CORRELATION BETWEEN MULTIDRUG-RESISTANT BACTERIOBILIA AND MORBIDITY AFTER PANCREATIC SURGERY	12
Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"	12
T.12.7 IS ONE PASS ENOUGH FOR THE DIAGNOSIS OF THE PANCREATIC MASSES DURING EUS-FNB? A PROSPECTIVE STUDY	12
OC.16.2 OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY IN THE ELDER POPULATION	12
AF.157 EUS-GUIDED GALLBLADDER DRAINAGE: A VALUABLE OPTION IN THE COVID-19 ERA	12
Where does capsule endoscopy fit in the diagnostic algorithm of small bowel intussusception?	11
Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt (PVR-TIPS) in patients with anatomical portal contraindication to liver transplantation: feasibility and clinical implication	11
OC.06.4 AGREEMENT BETWEEN REAL-TIME ELASTOGRAPHY AND DELAYED ENHANCEMENT MAGNETIC RESONANCE ENTEROGRAPHY ON QUANTIFYING BOWEL WALL FIBROSIS IN CROHN’S DISEASE	11
AF.13 SLEEP DISTURBANCES ACROSS ACHALASIA, EOSINOPHILIC ESOPHAGITIS AND GASTROESOPHAGEAL REFLUX DISEASE	11
T.07.1 NATURAL HISTORY AND CLINICAL IMPACT OF NON-NEOPLASTIC PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA	11
Detection of coronary artery disease in liver transplant recipients: does stress echocardiography still have a role?	11
AF.89 CHANGING DEMOGRAPHIC-CLINIC-PATHOLOGIC PROFILES OF NEWLY DIAGNOSED CARRIERS OF CHRONIC HEPATITIS B VIRUS INFECTION ACROSS TWO DECADES: A SINGLE ITALIAN REFERENCE CENTER REPORT	11
TREM1 facilitates the development of gastric cancer through regulating neutrophil extracellular traps-mediated macrophage polarization	11
Endoscopic ultrasound-guided drainage of pancreatic collections with dedicated metal stents: A nationwide, multicenter, propensity score-matched comparison	11
The role of miRNA in IBS pathogenesis, diagnosis and therapy: The latest thought	11
The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune checkpoint regulation in hep	11
AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY	11
T.04.3 USING A NEW ELECTROCAUTERY LUMEN APPOSING METAL STENT TO PERFORM AN EUS-GUIDED GASTROENTEROSTOMY IN TREATMENT OF GASTRIC OUTLET OBSTRUCTION	11
Prevalence and Characterization of Resistance Profiles of “Unusual” HCV Subtypes in Italy within the Italian Resistance Network Vironet C	11
Assessment of sarcopenia improves the prediction of post-TIPS mortality in older adult patients with cirrhosis	11
Author's reply: “Comment on “The association analysis between exposure to volatile organic compounds and fatty liver disease in US Adults””	11
Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma	11
More advanced presentation but similar survival for hepatocellular carcinoma in HIV positive compared to HIV-negative patients: a retrospective cohort analysis	11
Diagnostic yield of whole exome sequencing in adult-onset cholestatic liver disease	11
T.04.8 A MULTICENTRIC SURVEY ON THE AVAILABILITY AND USE OF ANESTHESIOLOGIST-DIRECTED CARE IN GASTROINTESTINAL ENDOSCOPY	11
T.05.2 DO WE NEED THREE DIFFERENT TYPES OF ESOPHAGOGASTRIC JUNCTION?	11
OC.11.6 UPPER ESOPHAGEAL SPHINCTER PARAMETERS IN EOSINOPHILIC ESOPHAGITIS: NEW PERSPECTIVES	11
Different immunological microenvironment in patients with different cirrhosis etiology and hepatocellular carcinoma	11
Role of rare and common variants in the diagnosis of adults with cryptogenic liver and lipid disorders	11
Efficacy and safety of cold snare polypectomy for sessile serrated polyps ≥ 10 mm: A systematic review and meta-analysis	10
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease	10
T.02.7 ANTHROPOMETRIC MEASUREMENTS, BODY COMPOSITION AND PREDICTIVE ROLE OF PHASE ANGLE IN WEIGHT LOSS AFTER BARIATRIC ENDOSCOPY: RESULTS FROM TWO SINGLE-CENTER, RANDOMIZED TRIALS	10
OC.15.2 ENDOSCOPIC TREATMENT OF PANCREATIC DUCT DISRUPTION AND CYSTIC DUCT LEAK USING CYANOACRYLATE: A CASE SERIES	10
OC.07.9 RISK FACTORS AND INCIDENCE OF DYSPLASIA/ ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH BARRETT’S ESOPHAGUS: DATA FROMA PROSPECTIVE, INTERNATIONAL, OBSVERVATIONAL STUDY - THE IOBER PROJECT	10
OC.14.4 EXPLORING MICROBIOTA-IMMUNE INTERACTIONS IN SHORT BOWEL SYNDROME AND CROHN’S DISEASE IN A MODEL OF HUMAN MICROBIOTA ASSOCIATED MICE	10
Clinical Significance of histologic healing in IBD: Evidence from randomized controlled trials (RCT) and real world (RW) data	10
Author's reply: “Predictors for the development of diabetes mellitus following acute pancreatitis”	10
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging concept	10
Reply to: “Liver fibrosis and adverse outcomes in COVID-19”	10
OC.19.3 CLINICAL RELEVANCE OF POSITIVE MOLECULAR STOOL TESTING FOR INTESTINAL PATHOGENS IN DIFFERENT GASTROINTESTINAL DISORDERS	10
OC.14.5 THERAPEUTIC MODULATION OF GUT MICROBIOME TO TREAT IMMUNE-CHECKPOINT INHIBITORS-RELATED DIARRHEA AND COLITIS: EXPERIENCE OF A MICROBIOME CLINIC	10
T.01.10 SELF-EXPANDING METAL STENT FOR REFRACTORY VARICEAL BLEEDING: AN UMBRELLA REVIEW WITH THE SYNTHESIS OF THE BEST EVIDENCE	10
An unexpected giant omental pseudocyst during a liver transplant	10
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance	10
Comparison of ciprofol–alfentanil and propofol–alfentanil sedation during bidirectional endoscopy: A prospective, double-blind, randomised, controlled trial	10
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis	10
Editorial Board	10
Proton pump inhibitor dosing patterns are less than optimal among new referrals to an outpatient gastroenterology clinic	10
OC.01.6 MOLECULAR SIGNATURE OF ESOPHAGEAL STRICTURE AFTER CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION: PRELIMINARY INSIGHTS FROM A PILOT STUDY	10
OC.02.20 SPLIT THE SPLIT: EFFICACY AND TOLERABILITY OF THE ASYMMETRIC SPLIT PREPARATION SCHEME WITH AVERY LOW VOLUME INTESTINAL PREPARATION: RANDOMIZED, SINGLEBLIND, PARALLEL-GROUP CLINICAL TRIAL	10
BOC.03.3 PERFORMANCE OF THREE ENDOSCOPIC GASTROPLASTY TECHNIQUES IN DIFFERENT OBESITY CLASSES. RESULTS AT 18 MONTHS FOLLOW-UP FROM A SINGLE CENTER, RANDOMIZED TRIAL	10
Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia	10
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD	10
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight	9
Optimal timing of endoscopy in pediatric variceal hemorrhage – How urgent is urgent?	9
Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: A retrospective multicenter study	9
Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based study	9
OC.15.1: DIAGNOSTIC YIELD OF AI-ASSISTED CAPSULE ENDOSCOPY: AN INTERIM ANALYSIS OF COMPARISON BETWEEN EXPERTS AND TRAINEES	9
OC.08.10: PROXIMAL ESOPHAGEAL IMPEDANCE BASELINE INCREASES THE YIELD OF IMPEDANCE-PH AND IS ASSOCIATED WITH RESPONSE TO PPIS IN CHRONIC COUGH PATIENTS	9
T.04.8: IBD PATIENTS SHOW WORRYING LEVELS OF SELF-REPORTED PHYSICAL INACTIVITY AS MEASURED BY THE INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE INDEPENDENTLY OF DISEASE ACTIVITY AND IBD PHENOTYPE: RES	9
Whether and when to biopsy coeliac patients: A never-ending story	9
Title Page	9
Foreign body ingestion in children: Definition of a nomogram to predict surgical or endoscopic intervention	9
Detection of potential pathogen in pancreatic fluid aspiration with metagenomic next-generation sequencing in patients with suspected infected pancreatic necrosis	9
Early thoracentesis correlated with survival benefit in patients with spontaneous bacterial empyema	9
Comparison of idiopathic recurrent acute pancreatitis [IRAP] and recurrent acute pancreatitis with genetic mutations	9
Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn’s disease	9
Comment on: Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study	9
OC.11.4: LIVER TRANSPLANT IN ACLF AND ALD: AN EFFECTIVE OPTION WITH LIMITED ACCESS? PRELIMINARY RESULTS OF A SINGLE CENTER EXPERIENCE	9
OC.13.5: PROTECTIVE EFFECTS OF ADENOSINE DEAMINASE RNA SPECIFIC 1 IN INFLAMMATORY BOWEL DISEASE	9
Antonio Ascione, 1941 - 2023: in memoriam	9
Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS)	9
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals	9
Delayed ERCP in the setting of severe acute cholangitis—How much delay is “Delayed”?	9
Antisense oligonucleotides rescue an intronic splicing variant in the ABCB11 gene that causes progressive familial intrahepatic cholestasis type 2	9
The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection	9
T.04.4 TOO MANY COUCH POTATOES AMONG MIDDLE-AGED INFLAMMATORY BOWEL DISEASE PATIENTS! FINDINGS FROM THE “BE-FIT-IBD-2” STUDY ON PATIENT-REPORTED PHYSICAL ACTIVITY LEVELS EXAMINING THEIR INTERACTIONS W	9
“Per ELISA”: Time to adopt anti-transglutaminase/deamidated gliadin peptide diagnostic combination in coeliac disease of adults?	9
OC.05.9: FATIGUE IS NOT INFLUENCED BY CHRONOTYPE AND IS REPORTED TO BE MAINLY MUSCULAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS	9
OC.18.11: LONG-TERM OUTCOMES OF MAINTENANCE THERAPY IN ADULT AND PEDIATRIC EOSINOPHILIC ESOPHAGITIS: A SYSTEMATIC REVIEW AND METANALYSIS	9
Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD	9
Assessing disease severity in inflammatory bowel disease - Can we reliably encompass the full burden of illness?	9
Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis	9
A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma	9
Erratum to “Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma” [Digestive and Liver Disease 56 (2024) 2011-2021]	8
T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA	8
Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review	8
Mannitol for bowel preparation: Efficacy and safety results from the SATISFACTION randomised clinical trial	8
OC.14.4 FEASIBILITY AND SAFETY OF A NEW DEDICATED BILIARY STENT FOR EUS-GUIDED HEPATICO-GASTROSTOMY: THE FIT STUDY	8